Bausch + Lomb Boston SimplusMulti-Action Solution, Bausch + Lomb Boston One Step Liquid Enzymatic Cleaner
Products, Contact Lens Care, Rigid Gas Permeable. 510(k) K181627, from Bausch & Lomb, Incorporated (Rochester, NY). Product code MRC, class 2.
As of Nov 17, 2026, K181627 is an FDA 510(k) held by Bausch & Lomb, Incorporated, substantially equivalent on Aug 10, 2018 after 51 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Aug 10, 2018
- Review time: 51 days
- Recalls: 0
- Cited as a predicate by: 2 devices
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFBausch + Lomb Boston Simplus Multi-Action Solution is indicated for cleaning, removing protein, rinsing, disinfecting, conditioning, storing and cushioning fluoro silicone acrylate and silicone acrylate rigid gas permeable contact lenses.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Boston BL-1000-SIM08 Multi-Action SolutionK024289 · Bausch & Lomb, Incorporated · May 2, 2003
- Boston Liquid Enzymatic CleanerK973217 · Polymer Technology Corp. · Nov 24, 1997
Cited as a Predicate
2 later 510(k) summaries name this device as a predicate- cleadew GP hydra oneK251876 · Ophtecs Corporation · Oct 9, 2025
- Boston One Step Liquid Enzymatic CleanerK200416 · Bausch & Lomb, Incorporated · Sep 23, 2020
Other MRC Clearances
The newest 510(k)s for the same product code; see every MRC device- cleadew GP hydra oneK251876 · Ophtecs Corporation · Oct 9, 2025
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 20, 2018
- Review panel
- Ophthalmic
- Regulation
- 21 CFR 886.5918
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files